Abstract
Preeclampsia is called a "promising disease" for us obstetricians with a bit of exaggeration. It occurs only during pregnancy, and predominantly, during its second half.
Characteristic symptoms can be traced at present in 5-8% of pregnant women and it can be assumed that this number will increase slightly in the future. The main culprit is the rapidly rising age of mothers, which is currently 27 years in the Czech Republic for primiparous.
According to the severity of the symptoms, preeclampsia is divided into mild, moderate and severe. The most serious form of the disease is eclampsia.
The risks of serious maternal complications, which can occasionally result in the death of a woman in untreated severe forms of the disease, are well known. The risks to the fetus are also sufficiently described.
It is mainly an intrauterine growth restriction (IUGR) very often associated with iatrogenic prematurity, because the only causal solution to the disease is termination of pregnancy and removal of the placenta. Children born with IUGR are currently the subject of many studies, mainly in connection with the presumed increased risk of cardiovascular disease in adulthood.
Many studies have not been published on the subsequent risks of mothers who have undergone preeclampsia during pregnancy. This is currently changing and research attention is turning to this issue.
From the works published so far, it can be concluded that preeclampsia poses certain risks for a woman in later life.